Jason Agulnik

1.6k total citations
68 papers, 1.0k citations indexed

About

Jason Agulnik is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Jason Agulnik has authored 68 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 36 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Jason Agulnik's work include Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Diagnosis and Treatment (26 papers) and Cancer Genomics and Diagnostics (13 papers). Jason Agulnik is often cited by papers focused on Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Diagnosis and Treatment (26 papers) and Cancer Genomics and Diagnostics (13 papers). Jason Agulnik collaborates with scholars based in Canada, United States and Germany. Jason Agulnik's co-authors include David Small, Goulnar Kasymjanova, Victor Cohen, Carmela Pepe, V. Cohen, Lama Sakr, Wilson H. Miller, Vicky Tagalakis, Gerald Batist and George Chong and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Jason Agulnik

61 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Agulnik Canada 18 580 506 167 136 110 68 1.0k
A. Scanni Italy 16 600 1.0× 849 1.7× 340 2.0× 151 1.1× 116 1.1× 48 1.3k
Alfredo Tartarone Italy 17 333 0.6× 432 0.9× 132 0.8× 236 1.7× 68 0.6× 61 1.1k
İdris Yücel Türkiye 13 101 0.2× 294 0.6× 131 0.8× 122 0.9× 54 0.5× 43 716
Özdal Dillioğlugil Türkiye 16 792 1.4× 163 0.3× 80 0.5× 115 0.8× 46 0.4× 65 1.2k
Sameer R. Ghate United States 17 374 0.6× 255 0.5× 107 0.6× 170 1.3× 17 0.2× 62 850
Taha Koray Şahin Türkiye 18 270 0.5× 561 1.1× 155 0.9× 200 1.5× 60 0.5× 83 1.1k
Luciano Frontini Italy 10 360 0.6× 615 1.2× 51 0.3× 65 0.5× 42 0.4× 16 943
James N. Frame United States 17 263 0.5× 329 0.7× 77 0.5× 164 1.2× 70 0.6× 41 995
Vincent Fradet Canada 24 934 1.6× 282 0.6× 315 1.9× 245 1.8× 55 0.5× 86 1.8k
Rex B. Mowat United States 14 124 0.2× 511 1.0× 161 1.0× 129 0.9× 150 1.4× 38 887

Countries citing papers authored by Jason Agulnik

Since Specialization
Citations

This map shows the geographic impact of Jason Agulnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Agulnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Agulnik more than expected).

Fields of papers citing papers by Jason Agulnik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Agulnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Agulnik. The network helps show where Jason Agulnik may publish in the future.

Co-authorship network of co-authors of Jason Agulnik

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Agulnik. A scholar is included among the top collaborators of Jason Agulnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Agulnik. Jason Agulnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melosky, Barbara, Quincy S. Chu, Rosalyn A. Juergens, et al.. (2025). Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLC. Lung Cancer. 208. 108717–108717.
2.
Alameddine, Raafat, Marie Florescu, Mustapha Tehfé, et al.. (2025). Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study). Current Oncology. 32(2). 57–57. 1 indexed citations
3.
4.
5.
Cohen, Victor, et al.. (2024). Sex-Related Differences in Immunotherapy Outcomes of Patients with Advanced Non-Small Cell Lung Cancer. Current Oncology. 31(11). 7379–7389. 2 indexed citations
6.
Pitrou, Isabelle, et al.. (2024). Lung Cancer Screening in Family Members and Peers of Patients With Lung Cancer: Protocol for a Prospective Cohort Study. JMIR Research Protocols. 14. e58529–e58529.
7.
Chen, Yue, S. Macisaac, Matthew D. Young, et al.. (2024). Nunavimmi puvakkut kaggutimik aanniaqarniq: Qanuilirqitaa?Lung cancer in Nunavik: How are we doing? A retrospective matched cohort study. Canadian Medical Association Journal. 196(6). E177–E186. 3 indexed citations
8.
Ezeife, Doreen A., Eldon Spackman, Rosalyn A. Juergens, et al.. (2022). The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer. Therapeutic Advances in Medical Oncology. 14. 27 indexed citations
9.
Laurie, Scott A., Jason Agulnik, Desirée Hao, et al.. (2020). 1195P The value of detecting resistance through liquid biopsy. Annals of Oncology. 31. S786–S787. 1 indexed citations
10.
Marques, Maud, Lise Tremblay, Nicole Bouchard, et al.. (2019). Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes. Molecular Cancer Therapeutics. 18(9). 1628–1636. 20 indexed citations
11.
Kasymjanova, Goulnar, R. Thomas Jagoe, Carmela Pepe, et al.. (2018). Does the Presence of Emphysema Increase the Risk of Radiation Pneumonitis in Lung Cancer Patients?. Current Oncology. 25(6). 610–614. 6 indexed citations
12.
Kempen, Léon C.L.T. van, Hangjun Wang, Alan Spatz, et al.. (2018). Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLC. Journal of Thoracic Oncology. 13(9). e161–e163. 10 indexed citations
13.
Ali, Adnan, Sophie Camilleri‐Broët, V. Cohen, et al.. (2018). P2.01-04 Reducing Time to Molecular Diagnosis for Advanced NSCLC in the Context of a Reference Testing Center. Journal of Thoracic Oncology. 13(10). S666–S666. 1 indexed citations
14.
15.
Hoffer, L. John, Line Robitaille, Robert Zakarian, et al.. (2015). High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial. PLoS ONE. 10(4). e0120228–e0120228. 88 indexed citations
16.
Kasymjanova, Goulnar, Chantal Robitaille, Victor Cohen, et al.. (2014). Comparison of the Yield of Different Diagnostic Procedures for Cellular Differentiation and Genetic Profiling of Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(8). 1120–1125. 7 indexed citations
17.
Chouaïd, C., Jason Agulnik, Erdem Göker, et al.. (2013). Health-Related Quality of Life and Utility in Patients with Advanced Non–Small-Cell Lung Cancer: A Prospective Cross-Sectional Patient Survey in a Real-World Setting. Journal of Thoracic Oncology. 8(8). 997–1003. 115 indexed citations
18.
Chouaïd, C., Jason Agulnik, Gerarda J.M. Herder, et al.. (2012). HEALTH-RELATED QUALITY OF LIFE IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS. Value in Health. 15(4). 1 indexed citations
19.
Smith, Benjamin M., et al.. (2010). Which Types of Lung Cancer Are Associated With Emphysema?. CHEST Journal. 138(4). 248A–248A. 1 indexed citations
20.
Agulnik, Jason, et al.. (2008). Retrospective Practice Review of Treatment of Metastatic Non-Small-Cell Lung Cancer with Second-Line Erlotinib. Current Oncology. 15(6). 279–285. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Scanni Breakdown of academic impact, for papers by Alfredo Tartarone Breakdown of academic impact, for papers by İdris Yücel Breakdown of academic impact, for papers by Özdal Dillioğlugil Breakdown of academic impact, for papers by Sameer R. Ghate Breakdown of academic impact, for papers by Taha Koray Şahin Breakdown of academic impact, for papers by Luciano Frontini Breakdown of academic impact, for papers by James N. Frame Breakdown of academic impact, for papers by Vincent Fradet Breakdown of academic impact, for papers by Rex B. Mowat
Rankless by CCL
2026